scPharmaceuticals Inc. to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 26 2019 - 8:00AM
Business Wire
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company
focused on developing and commercializing products that have the
potential to optimize the delivery of infused therapies, advance
patient care, and reduce healthcare costs, today announced that
John Tucker, chief executive officer, will present and host
investor meetings at the Piper Jaffray 31st Annual Healthcare
Conference being held at the Lotte New York Palace in New York, NY.
The Company is scheduled to present on Thursday, December 5, 2019,
at 8:50 a.m. ET.
A live webcast of the presentation can be accessed under “News
& Events” in the Investor Relations section of the Company’s
website, www.scpharmaceuticals.com, and will be archived for ninety
days.
About scPharmaceuticals scPharmaceuticals is a
pharmaceutical company focused on developing and commercializing
products that are designed to reduce healthcare costs and improve
health outcomes. The Company develops, internally and through
strategic partnerships, innovative products and solutions that aim
to expand and advance the outpatient care of select acute
conditions. The Company’s lead programs focus on the subcutaneous,
self-administration of IV-strength treatments in heart failure and
infectious disease. scPharmaceuticals is headquartered in
Burlington, MA. For more information, please visit
scPharmaceuticals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191126005172/en/
Katherine Taudvin, scPharmaceuticals Inc. 781-301-6706
ktaudvin@scpharma.com
Christopher F. Brinzey, Westwicke an ICR Company 339-970-2843
chris.brinzey@westwicke.com
scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Apr 2023 to Apr 2024